Re: Farmas USA
Horizon Pharma plc Announces District Court Decision to Uphold PENNSAID® (diclofenac sodium topical solution) 2% w/w Patent
Patent Covering PENNSAID® 2% Infringed by a Proposed Generic Developed by Actavis Laboratories UT, Inc.
http://ir.horizon-pharma.com/releasedetail.cfm?ReleaseID=1026352
Justo estaba mirando la noticia...
Hznp